Diagnostic and prognostic performance to detect Alzheimer’s disease and clinical progression of a novel assay for plasma p-tau217

Diagnostic and prognostic performance to detect Alzheimer’s disease and clinical progression of a novel assay for plasma p-tau217

Abstract Background Recent advances in disease-modifying treatments highlight the need for accurately identifying individuals in early Alzheimer’s disease (AD) stages and for monitoring of treatment effects. Plasma measurements of phosphorylated tau (p-tau) are a promising biomarker for AD, but diff...

Full description

Bibliographic Details
Main Authors: Colin Groot, Claudia Cicognola, Divya Bali, Gallen Triana-Baltzer, Jeffrey L. Dage, Michael J. Pontecorvo, Hartmuth C. Kolb, Rik Osssenkoppele, Shorena Janelidze, Oskar Hansson
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Mild cognitive impairment
Plasma biomarkers
p-tau
Assay
Online Access:https://doi.org/10.1186/s13195-022-01005-8

Internet

https://doi.org/10.1186/s13195-022-01005-8

Similar Items